Cargando…
Preparation and Characterization of Two Immunogens and Production of Polyclonal Antibody with High Affinity and Specificity for Darunavir
Darunavir (DRV) is a potent antiviral drug used for treatment of infections with human immunodeficiency virus (HIV). Effective and safe treatment with DRV requires its therapeutic drug monitoring (TDM) in patient’s plasma during therapy. To support TDM of DRV, a specific antibody with high affinity...
Autores principales: | Darwish, Ibrahim A., Almehizia, Abdulrahman A., Radwan, Awwad A., Herqash, Rashed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570924/ https://www.ncbi.nlm.nih.gov/pubmed/32906585 http://dx.doi.org/10.3390/molecules25184075 |
Ejemplares similares
-
Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma
por: Darwish, Ibrahim A, et al.
Publicado: (2012) -
Preparation and Characterization of a Polyclonal Antibody against Brominated Protein
por: Kambayashi, Yasuhiro, et al.
Publicado: (2009) -
Requirement of a Blocking Step in Affinity Purification of Polyclonal Antibodies
por: Hamzehlou, Sepideh, et al.
Publicado: (2015) -
Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin
por: Almehizia, Abdulrahman A., et al.
Publicado: (2020) -
Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib
por: Al-Shehri, Mona M., et al.
Publicado: (2019)